SCHEMBL7155245

SCHEMBL7155245

CCOCC(F)(F)C(F)(F)C(F)(F)C(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2C9 P11712 1/20 0.35
RECQL P46063 1/20 0.35
TSHR P16473 2/20 0.33
USP2 O75604 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9588106 0.92 CYP1A2 (0.42) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL13096919 0.92 CYP1A2 (0.42) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL7151574 0.86
SCHEMBL497555 0.86 LMNA (0.43) CYP1A2CYP2C19LMNANPSR1HPGD
Hydrochloric Acid SCHEMBL31364520 0.84 LMNA (0.42) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL9928685 0.80 LMNA (0.40) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL1758474 0.80 LMNA (0.40) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL7156399 0.80 LMNA (0.43) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL12826809 0.79 LMNA (0.53) CYP1A2CYP2C19LMNANPSR1HPGD
SCHEMBL1758932 0.78 NPSR1 (0.39) CYP1A2CYP2C19LMNANPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260058207-A1 ELECTROLYTE COMPOSITION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY CONTAINING THE SAME HYUNDAI MOTOR CO LTD (KR) 2026-02-26 US claimed
CN-118117175-A Sodium ion battery 深圳新宙邦科技股份有限公司 2024-05-31 CN claimed
US-20260058207-A1 ELECTROLYTE COMPOSITION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY CONTAINING THE SAME HYUNDAI MOTOR CO LTD (KR) 2026-02-26 US disclosed
US-20260058207-A1 ELECTROLYTE COMPOSITION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY CONTAINING THE SAME HYUNDAI MOTOR CO LTD (KR) 2026-02-26 US disclosed
EP-0757399-B1 Non-aqueous electrolyte and lithium secondary battery SUMITOMO CHEMICAL CO (JP) 2003-04-02 EP disclosed
US-5795677-A Non-aqueous electrolyte and lithium secondary battery SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-08-18 US disclosed
EP-0757399-A1 Non-aqueous electrolyte and lithium secondary battery SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260058207-A1 ELECTROLYTE COMPOSITION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY CONTAINING THE SAME LEF1, FLI1, CACNA1F CYP1A2 2931/4885CYP2C19 2446/4885LMNA 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.